Compare Stocks: A, XLV, ILMN, and WAT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
A Agilent Technologies	$146.04 +3.3%	$134.16	$108.35 ▼ $160.27	$41.23B	1.25	2.05 million shs	1.53 million shs
ILMN Illumina	$187.96 -3.0%	$181.13	$88.00 ▼ $207.00	$28.38B	1.45	2.00 million shs	1.83 million shs
WAT Waters	$406.94 +1.8%	$373.23	$275.05 ▼ $414.15	$39.95B	1.19	897,753 shs	888,557 shs
XLV Health Care Select Sector SPDR Fund	$165.68 +0.7%	$158.11	$129.23 ▼ $168.53	$42.67B	0.56	12.07 million shs	7.97 million shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
A Agilent Technologies	+3.32%	+5.58%	+13.41%	+26.42%	+28.88%
ILMN Illumina	-2.97%	-8.36%	+0.08%	+32.48%	+99.05%
WAT Waters	+1.83%	+7.73%	+10.15%	+14.59%	+46.38%
XLV Health Care Select Sector SPDR Fund	+0.75%	+1.93%	+2.08%	+15.46%	+26.95%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
A Agilent Technologies	$146.04 +3.3%	$134.16	$108.35 ▼ $160.27	$41.23B	1.25	2.05 million shs	1.53 million shs
ILMN Illumina	$187.96 -3.0%	$181.13	$88.00 ▼ $207.00	$28.38B	1.45	2.00 million shs	1.83 million shs
WAT Waters	$406.94 +1.8%	$373.23	$275.05 ▼ $414.15	$39.95B	1.19	897,753 shs	888,557 shs
XLV Health Care Select Sector SPDR Fund	$165.68 +0.7%	$158.11	$129.23 ▼ $168.53	$42.67B	0.56	12.07 million shs	7.97 million shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
A Agilent Technologies	+3.32%	+5.58%	+13.41%	+26.42%	+28.88%
ILMN Illumina	-2.97%	-8.36%	+0.08%	+32.48%	+99.05%
WAT Waters	+1.83%	+7.73%	+10.15%	+14.59%	+46.38%
XLV Health Care Select Sector SPDR Fund	+0.75%	+1.93%	+2.08%	+15.46%	+26.95%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
A Agilent Technologies	2.89	Moderate Buy	$159.35	9.12% Upside
ILMN Illumina	2.47	Hold	$188.40	0.23% Upside
WAT Waters	2.75	Moderate Buy	$418.10	2.74% Upside
XLV Health Care Select Sector SPDR Fund	2.78	Moderate Buy	$165.68	N/A

Current Analyst Ratings Breakdown

Latest A, XLV, ILMN, and WAT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/5/2026	WAT Waters	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$430.00
8/5/2026	ILMN Illumina	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold
8/5/2026	WAT Waters	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$400.00
8/5/2026	WAT Waters	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$420.00
8/5/2026	WAT Waters	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$435.00 ➝ $475.00
8/5/2026	WAT Waters	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$420.00
8/5/2026	WAT Waters	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$408.00 ➝ $475.00
8/5/2026	WAT Waters	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$425.00 ➝ $460.00
8/5/2026	WAT Waters	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$370.00 ➝ $400.00
8/3/2026	ILMN Illumina	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$190.00 ➝ $205.00
8/3/2026	ILMN Illumina	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Sell	$95.00 ➝ $113.00

(Data available from 8/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
A Agilent Technologies	$6.95B	5.94	$6.64 per share	22.01	$23.78 per share	6.14
ILMN Illumina	$4.34B	6.54	$6.72 per share	27.99	$18.80 per share	10.00
WAT Waters	$3.17B	12.62	$16.63 per share	24.47	$154.76 per share	2.63
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
A Agilent Technologies	$1.30B	$4.98	29.32	22.16	2.59	19.55%	24.33%	12.99%	8/26/2026 (Estimated)
ILMN Illumina	$850M	$5.36	35.07	30.91	2.65	18.36%	29.84%	12.17%	N/A
WAT Waters	$642.63M	$4.01	101.48	24.66	2.36	3.58%	11.27%	6.73%	N/A
XLV Health Care Select Sector SPDR Fund	N/A	N/A	21.15	N/A	N/A	N/A	N/A	N/A	N/A

Latest A, XLV, ILMN, and WAT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/26/2026	Q3 2026	A Agilent Technologies	$1.49	N/A	N/A	N/A	$1.84 billion	N/A
8/4/2026	Q2 2026	WAT Waters	$3.01	$3.05	+$0.04	-$1.39	$1.62 billion	$1.65 billion
7/30/2026	Q2 2026	ILMN Illumina	$1.23	$1.31	+$0.08	$1.35	$1.13 billion	$1.16 billion
5/27/2026	Q2 2026	A Agilent Technologies	$1.41	$1.49	+$0.08	$1.20	$1.80 billion	$1.84 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
A Agilent Technologies	$1.02	0.70%	+6.58%	20.48%	9 Years
ILMN Illumina	N/A	N/A	N/A	N/A	N/A
WAT Waters	N/A	N/A	N/A	N/A	N/A
XLV Health Care Select Sector SPDR Fund	$2.53	1.53%	N/A	N/A	N/A

Latest A, XLV, ILMN, and WAT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/20/2026	A Agilent Technologies	quarterly	$0.2550	0.77%	6/30/2026	6/30/2026	7/22/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
A Agilent Technologies	0.43	2.10	1.62
ILMN Illumina	0.53	1.80	1.40
WAT Waters	0.32	0.77	1.13
XLV Health Care Select Sector SPDR Fund	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
A Agilent Technologies	N/A
ILMN Illumina	89.42%
WAT Waters	94.01%
XLV Health Care Select Sector SPDR Fund	N/A

Insider Ownership

Company	Insider Ownership
A Agilent Technologies	N/A
ILMN Illumina	2.90%
WAT Waters	0.31%
XLV Health Care Select Sector SPDR Fund	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
A Agilent Technologies	18,100	282.43 million	N/A	Optionable
ILMN Illumina	8,650	151.00 million	146.62 million	Optionable
WAT Waters	7,900	98.19 million	97.88 million	Optionable
XLV Health Care Select Sector SPDR Fund	N/A	257.57 million	N/A	Not Optionable

A, XLV, ILMN, and WAT Headlines

Recent News About These Companies

Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?

August 8 at 11:33 AM | fool.com

Broad Market Momentum & Defensive Pivots: This Week's Top ETF Flows

August 7 at 3:43 PM | etftrends.comE

4 Healthcare Stocks to Watch as Defensive Demand Strengthens

August 7 at 10:01 AM | zacks.com

State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?

August 5 at 6:51 PM | finance.yahoo.com

Showstopper Healthcare Earnings Elevate Use Case for XLV

August 5 at 12:32 PM | etftrends.comE

Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in July 2026

August 3, 2026 | seekingalpha.com

Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?

August 3, 2026 | fool.com

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

August 1, 2026 | fool.com

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

August 1, 2026 | fool.com

XLV vs. IHE: Which Healthcare ETF Is the Better Buy?

July 31, 2026 | finance.yahoo.com

Financial Sector ETF Hits Record High on Fintech Gains

July 28, 2026 | etftrends.comE

UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch

July 27, 2026 | zacks.com

XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio?

July 27, 2026 | finance.yahoo.com

PINK vs. XLV: How Do These Two Health Care ETFs Match Up?

July 26, 2026 | fool.com

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?

July 26, 2026 | fool.com

Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?

July 21, 2026 | theglobeandmail.com

Risk-Wary Family Offices Double Down on Infrastructure

July 21, 2026 | etftrends.comE

XLV: Healthcare Sector On The Mend, But Probably Not For Long

July 18, 2026 | seekingalpha.com

Seeking Alpha’s quant spotlight: Highest and lowest rated healthcare stocks ahead of Q2

July 17, 2026 | msn.com

Drug Pipeline Wins State Street Over on Healthcare

July 14, 2026 | etftrends.comE

These Stocks Could Be the Biggest Winners of the 2026 Midterms (XLV)

...

May 18, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

A, XLV, ILMN, and WAT Company Descriptions

Agilent Technologies NYSE:A

$146.04 +4.70 (+3.32%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$145.71 -0.33 (-0.22%)

As of 08/7/2026 07:43 PM Eastern

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Illumina NASDAQ:ILMN

$187.96 -5.76 (-2.97%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$187.82 -0.14 (-0.07%)

As of 08/7/2026 07:57 PM Eastern

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Waters NYSE:WAT

$406.94 +7.24 (+1.81%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$406.90 -0.04 (-0.01%)

As of 08/7/2026 07:34 PM Eastern

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Health Care Select Sector SPDR Fund NYSEARCA:XLV

$165.68 +1.23 (+0.75%)

Closing price 08/7/2026 04:10 PM Eastern

Extended Trading

$165.14 -0.54 (-0.33%)

As of 08/7/2026 07:59 PM Eastern

Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest A, XLV, ILMN, and WAT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest A, XLV, ILMN, and WAT Earnings

Compare Dividends

Latest A, XLV, ILMN, and WAT Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

A, XLV, ILMN, and WAT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

A, XLV, ILMN, and WAT Company Descriptions

Agilent Technologies NYSE:A

Illumina NASDAQ:ILMN

Waters NYSE:WAT

Health Care Select Sector SPDR Fund NYSEARCA:XLV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools